Evotec AG (EVOTF.PK,EVTCY.PK) announced that it has extended its drug discovery alliance with Genentech, a member of the Roche Group (RHHBY.PK), for three additional years.
Evotec said that the collaboration was initiated in May 2010 and this extension further validates Evotec's technology platform and broad expertise in drug discovery.
Mario Polywka, Chief Operating Officer of Evotec, said, "We are delighted and proud that Genentech has decided to extend the current agreement. Both sets of scientists have collaborated very closely over the past few years and this extension is validation of the value we bring to Genentech's discovery programmes.
For comments and feedback contact: editorial@rttnews.com
Business News
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.